MARKET

RVMD

RVMD

Revolution Medicines, Inc.
NASDAQ
95.87
-1.08
-1.11%
Opening 12:04 02/02 EST
OPEN
96.52
PREV CLOSE
96.95
HIGH
97.50
LOW
95.30
VOLUME
632.42K
TURNOVER
--
52 WEEK HIGH
124.49
52 WEEK LOW
29.17
MARKET CAP
18.53B
P/E (TTM)
-18.5152
1D
5D
1M
3M
1Y
5Y
1D
Revolution Medicines price target raised to $122 from $92 at JPMorgan
TipRanks · 4h ago
Weekly Report: what happened at RVMD last week (0126-0130)?
Weekly Report · 6h ago
Did RMC-5127’s First-in-Human Trial Launch Just Shift Revolution Medicines' (RVMD) Investment Narrative?
Simply Wall St · 6h ago
REVOLUTION MEDICINES INC <RVMD.O>: JP MORGAN RAISES TARGET PRICE TO $122.00 FROM $92.00
Reuters · 12h ago
Analysts Conflicted on These Healthcare Names: Revolution Medicines (RVMD), Roche Holding AG (OtherRHHVF) and Incyte (INCY)
TipRanks · 2d ago
Interesting RVMD Put And Call Options For May 15th
NASDAQ · 3d ago
REVOLUTION MEDICINES INC <RVMD.O>: RAYMOND JAMES RAISES TARGET PRICE TO $135 FROM $76
Reuters · 3d ago
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance
Seeking Alpha · 3d ago
More
About RVMD
Revolution Medicines, Inc. is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target key nodes in the RAS pathway or associated pathways, which it refers to as RAS Companion Inhibitors. Its RAS(ON) Inhibitors are designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or in combination with RAS Companion Inhibitors or other therapeutic agents. The company’s RAS(ON) inhibitors are daraxonrasib (RMC-6236), an RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), an RAS(ON) G12C-selective inhibitor; and zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor, are in clinical development. The Company’s pipeline also focuses on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C).

Webull offers Revolution Medicines Inc stock information, including NASDAQ: RVMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVMD stock methods without spending real money on the virtual paper trading platform.